Cargando…
Oncobiosis and Microbial Metabolite Signaling in Pancreatic Adenocarcinoma
Pancreatic adenocarcinoma is one of the most lethal cancers in both men and women, with a median five-year survival of around 5%. Therefore, pancreatic adenocarcinoma represents an unmet medical need. Neoplastic diseases, such as pancreatic adenocarcinoma, often are associated with microbiome dysbio...
Autores principales: | Kiss, Borbála, Mikó, Edit, Sebő, Éva, Toth, Judit, Ujlaki, Gyula, Szabó, Judit, Uray, Karen, Bai, Péter, Árkosy, Péter |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7281526/ https://www.ncbi.nlm.nih.gov/pubmed/32344895 http://dx.doi.org/10.3390/cancers12051068 |
Ejemplares similares
-
The role of the microbiome in ovarian cancer: mechanistic insights into oncobiosis and to bacterial metabolite signaling
por: Sipos, Adrienn, et al.
Publicado: (2021) -
The involvement of oncobiosis and bacterial metabolite signaling in metastasis formation in breast cancer
por: Kovács, Tünde, et al.
Publicado: (2021) -
Cadaverine, a metabolite of the microbiome, reduces breast cancer aggressiveness through trace amino acid receptors
por: Kovács, Tünde, et al.
Publicado: (2019) -
Microbiome—Microbial Metabolome—Cancer Cell Interactions in Breast Cancer—Familiar, but Unexplored
por: Mikó, Edit, et al.
Publicado: (2019) -
Indolepropionic Acid, a Metabolite of the Microbiome, Has Cytostatic Properties in Breast Cancer by Activating AHR and PXR Receptors and Inducing Oxidative Stress
por: Sári, Zsanett, et al.
Publicado: (2020)